Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines

Expert Rev Vaccines. 2020 Sep;19(9):781-784. doi: 10.1080/14760584.2020.1825946. Epub 2020 Oct 6.

Authors

Leonard Moise^{1

2

3}, Ted M Ross³, Daniel F Hoft⁴, William D Martin¹, Anne S De Groot^{1

3}

Affiliations

¹ EpiVax, Inc ., Providence, RI, USA.
² Institute for Immunology and Informatics, University of Rhode Island , Providence, RI, USA.
³ Center for Vaccines and Immunology, University of Georgia , Athens, GA, USA.
⁴ Departments of Molecular Microbiology & Immunology and Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University , St. Louis, MO, USA.

PMID: 32962468
DOI: 10.1080/14760584.2020.1825946

No abstract available

Keywords: COVID-19; SARS-CoV-2; T cell; T cell epitope; antibody; coronavirus; vaccine.

Publication types

Editorial

MeSH terms

Betacoronavirus / genetics
Betacoronavirus / immunology*
COVID-19
COVID-19 Vaccines
Coronavirus Infections / immunology
Coronavirus Infections / prevention & control*
Coronavirus Infections / virology
Humans
Pandemics / prevention & control*
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / virology
SARS-CoV-2
T-Lymphocytes / immunology
Viral Vaccines / immunology*

Substances

COVID-19 Vaccines
Viral Vaccines